论文部分内容阅读
观察促肝细胞生长素（PHGF，80～100mg／d）治疗重症肝炎病人的疗效，结果病人血浆中过氧化脂质（LPO，702±3．08μmol／L）显著低于对照组（10．08±3．64μmol／L），并发症发生率降低，存活率增加。
To observe the curative effect of hepatocyte growth-promoting factor (PHGF, 80-100 mg / d) on patients with severe hepatitis. The results showed that the level of LPO (702 ± 3.08μmol / L) was significantly lower than that of the control group ± 3.64μmol / L), the incidence of complications decreased, the survival rate increased.